Ontology highlight
ABSTRACT: Background
Epithelial-mesenchymal transition (EMT) has been believed to be related with chemotherapy resistance in non-small cell lung cancer (NSCLC). Recent studies have suggested eIF5A-2 may function as a proliferation-related oncogene in tumorigenic processes.Methods
We used cell viability assays, western blotting, immunofluorescence, transwell-matrigel invasion assay, wound-healing assay combined with GC7 (a novel eIF5A-2 inhibitor) treatment or siRNA interference to investigate the role of eIF5A-2 playing in NSCLC chemotherapy.Results
We found low concentrations of GC7 have little effect on NSCLC viability, but could enhance cisplatin cytotoxicity in NSCLC cells. GC7 also could reverse mesenchymal phenotype in NCI-H1299 and prevented A549 cells undergoing EMT after TGF-?1 inducement. eIF5A-2 knockdown resulted in EMT inhibition.Conclusion
Our data indicated GC7 enhances cisplatin cytotoxicity and prevents the EMT in NSCLC cells by inhibiting eIF5A-2.
SUBMITTER: Xu G
PROVIDER: S-EPMC4232729 | biostudies-literature | 2014 Nov
REPOSITORIES: biostudies-literature
Xu Guodong G Yu Hui H Shi Xinbao X Sun Lebo L Zhou Qingyun Q Zheng Dawei D Shi Huoshun H Li Ni N Zhang Xianning X Shao Guofeng G
BMC pulmonary medicine 20141107
<h4>Background</h4>Epithelial-mesenchymal transition (EMT) has been believed to be related with chemotherapy resistance in non-small cell lung cancer (NSCLC). Recent studies have suggested eIF5A-2 may function as a proliferation-related oncogene in tumorigenic processes.<h4>Methods</h4>We used cell viability assays, western blotting, immunofluorescence, transwell-matrigel invasion assay, wound-healing assay combined with GC7 (a novel eIF5A-2 inhibitor) treatment or siRNA interference to investig ...[more]